Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00632372 · ClinicalTrials.gov registry record
Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 8
- Enrollment target
NCT00632372 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 8 participants.
The verdict
NCT00632372 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to collect and analyze electrical measurements, timing, and signals from a CRT-D device in heart failure patients who either already have an implanted left atrial pressure sensor or will undergo a simultaneous implantation of a left atrial pressure sensor and a CRT-D device. These devices may be placed at the same time or separately (staged procedure) at the discretion of the investigator. A comparison will be made between the information gathered from the CRT-D system and the information gathered by the left atrial pressure sensor.
Interventions
- DEVICE Cardiac Resynchronization Therapy
- DEVICE HeartPOD™ System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2008-01 |
| Est. Completion | 2015-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00632372
The ClinicalTrials.gov registry entry for NCT00632372 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cardiac Resynchronization Therapy is the first listed.
NCT00632372 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00632372 about?
NCT00632372 is a clinical study titled "Cardiac Resynchronization Therapy (CRT) Based Heart Failure Monitoring Study". The purpose of this study is to collect and analyze electrical measurements, timing, and signals from a CRT-D device in heart failure patients who either already have an implanted left atrial pressure sensor or will undergo a simultaneous implantation of a left atrial pressure sensor and a CRT-D dev...
What is the current status of trial NCT00632372?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2008-01. Estimated completion is 2015-12.
What interventions are being tested in trial NCT00632372?
The interventions under investigation include: Cardiac Resynchronization Therapy (DEVICE), HeartPOD™ System (DEVICE).
Who is sponsoring clinical trial NCT00632372?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.